Next |
home / stock / xsnx / xsnx message board
Subject | By | Source | When |
---|---|---|---|
Looks good today on low vol, watching | InvestorNews1 | investorshub | 02/15/2023 8:25:32 PM |
Unfortunately... | splintered sunlight | investorshub | 01/26/2023 4:52:23 PM |
Looks like $XSNX is owning up to owing | BooDog | investorshub | 01/26/2023 4:09:49 PM |
What do you make of this? | splintered sunlight | investorshub | 01/24/2023 2:17:48 PM |
8K yesterday..... | splintered sunlight | investorshub | 01/24/2023 1:53:03 PM |
Something smells fishy here.... | splintered sunlight | investorshub | 01/12/2023 7:16:44 PM |
Thanks - I will get familiar with $XSNX | splintered sunlight | investorshub | 01/06/2023 3:54:31 PM |
They've got things happening, just not getting their | BooDog | investorshub | 01/06/2023 3:28:16 PM |
Going to read the board over the weekend. | splintered sunlight | investorshub | 01/06/2023 3:12:22 PM |
NovAccess Global Receives FDA Approval of Orphan Drug | BooDog | investorshub | 10/26/2022 2:54:18 PM |
NovAccess Global Announces Fireside Chat with Board Member Perspectives | BooDog | investorshub | 10/25/2022 5:49:12 PM |
Read the 8K and understand the dilution this | BooDog | investorshub | 10/05/2022 9:39:14 PM |
Welcome to what dark side? | cashmagnet | investorshub | 10/05/2022 9:30:32 PM |
I'm a small-fry investor with a minor stake | cashmagnet | investorshub | 10/05/2022 9:25:02 PM |
Thinking .01 until they file their IND. | BooDog | investorshub | 09/30/2022 2:11:23 PM |
Whelp, welcome to the dark side. | BooDog | investorshub | 09/30/2022 11:04:10 AM |
https://novaccessglobal.com/news/ Some good stuff in there. And | BooDog | investorshub | 09/28/2022 5:58:42 PM |
With that news, it's a shame this isn't | TRADER99 | investorshub | 07/19/2022 7:01:05 PM |
whytestocks: $XSNX News Article - CORRECTION: NovAccess Global Announces Filing of Orphan Drug Appli | whytestocks | investorshangout | 07/19/2022 4:55:54 PM |
whytestocks: $XSNX News Article - NovAccess Global Announces Filing of Orphan Drug Application for T | whytestocks | investorshangout | 07/19/2022 4:52:14 PM |
News, Short Squeeze, Breakout and More Instantly...
CLEVELAND, OH / ACCESSWIRE / April 30, 2024 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing a novel immunotherapy for patients suffering from cancers of the central nervous system, today announced the procurement of a new intellectual property license from Cedars-Sinai Medi...
CLEVELAND, OH / ACCESSWIRE / March 1, 2024 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing novel immunotherapies for brain tumor patients, today provided an update on business developments, financing and the 2024 annual meeting. The previously disclosed $10.7 million finan...
First Solar Inc. (FSLR) is expected to report $3.19 for Q4 2023 VIZIO Holding Corp. Class A (VZIO) is expected to report $0.02 for Q4 2023 Henry Schein Inc. (HSIC) is expected to report $0.71 for Q4 2023 Republic Services Inc. (RSG) is expected to report $1.28 for Q4 2023 Forge Gl...